home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Cheap Alternative For Large Scale RNA Interference Screens

  March, 21 2007 9:10
your information resource in human molecular genetics
A cost-effective resource for RNA interference (RNAi) that allows the effective reduction of gene expression is presented online in Nature Methods.

RNAi is a process by which short stretches of RNA knock down the expression of specific genes. To trigger this process at will, scientists most commonly use synthetic 'small interfering' (si)RNAs. Their advantage is that they can be designed to precisely target a sequence of choice within a gene; their disadvantage is that they are expensive. A large RNAi screen that targets many genes is thus financially impossible for a lot of academic laboratories. Frank Buchholz and colleagues previously developed a method to generate siRNAs enzymatically -- which makes them a lot cheaper but does not allow targeting of a particular sequence within a gene. Instead, the method creates a random pool of various siRNAs, some more effective than others, directed against a gene of interest. This presented a conundrum to many researchers who were intrigued by an easily accessible resource but doubted its efficacy in large screens.

The authors now introduce a selection step in their enzymatic synthesis process that makes the pool of enzymatically generated siRNAs more specific. The group shows that these enzymatically generated siRNAs work equally well, if not better, than synthetic siRNAs in a large RNAi screen, at a fraction of the cost.

Author contact:

Frank Buchholz, (Max Planck Institute, Dresden, Germany)
E-mail: buchholz@mpi-cbg.de

Abstract available online.

(C) Nature Methods press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.